Mitsui Chemicals said on Monday it will jointly acquire JSR Corp. with the Development Bank of Japan for 1.84 trillion yen, roughly $12 billion at current exchange rates, betting that AI-driven chip demand will keep advanced resin and photoresist suppliers in short supply for years.
What the deal does
JSR makes specialty chemicals used in semiconductor lithography and packaging, materials that fabs cannot swap out without long qualification cycles. Mitsui Chemicals has been building its electronics portfolio for several seasons; buying JSR would fold one of Japan’s last independent suppliers of cutting-edge photoresists into a group that already sells films, adhesives, and battery components.
The companies said they aim to complete the acquisition in the second half of the fiscal year ending March 2028, subject to shareholder and regulatory approvals. Mitsui did not detail the split of equity between itself and the state-backed development bank, but public statements framed the bank’s role as supporting a strategic asset during a wave of consolidation across the chip supply chain.
Why AI matters here
Foundries and memory makers are racing to add capacity for processors used in data centers. That build-out increases demand for resists, underlayers, and packaging substrates with tighter tolerances than consumer-grade plastics. JSR’s customer list includes major Asian and U.S. chip producers; losing it as a stand-alone bidder could reduce competition among suppliers, a point antitrust reviewers in Tokyo and Brussels typically examine in deals of this size.
Analysts who follow Japanese chemicals said the price reflects JSR’s margin profile in high-end materials rather than its smaller commodity lines. Mitsui executives told reporters the purchase ranks among the largest in Japan’s chemical industry in recent memory and signals that materials makers expect the AI capex cycle to run longer than prior smartphone-driven waves.
Shareholders and timing
JSR’s board will need to recommend terms to investors, and Mitsui will have to disclose financing and any competing offers under Tokyo exchange rules. Trading in both companies was closely watched Monday as investors priced in a control premium. If shareholders approve, integration planning would likely start around photoresist R&D sites in Japan and customer-facing technical support teams in Taiwan and South Korea.
Mitsui said the tie-up is designed to speed development of next-generation materials for sub-2-nanometer nodes and advanced chiplet packaging, areas where customers are already asking suppliers for co-development agreements. Failure to close would leave JSR as one of the few mid-cap Japanese material names still trading independently, but Monday’s announcement suggests both sides view full ownership as the more durable structure.
What comes next
Regulators are expected to focus on whether the combination would concentrate photoresist supply for leading-edge fabs. Labor groups at JSR plants in Yokkaichi and elsewhere will also watch whether Mitsui preserves research budgets after the transaction. Closure in fiscal 2027 would land just as several new megafabs in Japan and the United States are scheduled to begin high-volume production, timing that Mitsui executives described as critical for locking in long-term supply contracts.